Serial #90767113
DEAD

Serial Number

90767113

Owner

TRANSLATE BIO, INC.

Attorney

Alexandra Kochian

Filing Date

Jun 10, 2021

Add to watchlist:

No watchlists yet
View on USPTO

Serial #90767113 Trademark

Serial Number: 90767113

Serial #90767113 is a trademark filed by TRANSLATE BIO, INC. on June 10, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

TRANSLATE BIO, INC. (7 trademarks)

Lexington, MA 02421

Entity Type: 03

Trademark Details

Filing Date

June 10, 2021

Registration Date

Not Registered

Published for Opposition

June 14, 2022

Goods & Services

Pharmaceutical preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; medicines for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biotherapeutics, namely, biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biosimilars, namely, biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; therapeutic and prophylactic vaccines

Scientific research in the fields of pharmaceuticals, medicines, biologics, therapeutics, biotherapeutics, biosimilars, and therapeutic and prophylactic vaccines

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 15, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 15, 2025 ABN6
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 30, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 30, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 30, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 30, 2025 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 18, 2025 EXRA
SOU EXTENSION 5 GRANTED
Apr 18, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 17, 2025 AITU
SOU EXTENSION 5 FILED
Jan 15, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 15, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 17, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jun 17, 2024 EX4G
SOU EXTENSION 4 FILED
Jun 17, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 17, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 12, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jan 10, 2024 EX3G
SOU EXTENSION 3 FILED
Jan 10, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 10, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 17, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 17, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 17, 2023 REAP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 26, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 26, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 26, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 26, 2023 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 11, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jul 7, 2023 EX2G
SOU EXTENSION 2 FILED
Jul 7, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 7, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 9, 2023 EXRA
SOU EXTENSION 1 GRANTED
Feb 7, 2023 EX1G
SOU EXTENSION 1 FILED
Feb 7, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 7, 2023 EEXT
ASSIGNED TO EXAMINER
Oct 17, 2022 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 9, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 14, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 14, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 25, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 12, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
May 12, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 12, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 12, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 12, 2022 CNEA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 5, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 5, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 5, 2022 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 16, 2021 GNRN
NON-FINAL ACTION E-MAILED
Nov 16, 2021 GNRT
NON-FINAL ACTION WRITTEN
Nov 16, 2021 CNRT
ASSIGNED TO EXAMINER
Nov 2, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 1, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 31, 2021 NWOS
NEW APPLICATION ENTERED
Jun 14, 2021 NWAP